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The 1990s have seen an increase in illicit drug 
consumption in Croatia. A number of rapid screening 
assays and quantitative GC/MS methods have been 
developed for the determination of drugs in urine 
(1). However, urine sampling time is critical because 
all drugs, with the exception of marihuana, can be 
detected in urine only within 2–3 days after the 
use (2). Urine testing provides a reliable answer for 
recent intake. These limitations urged for a biological 
marker which could yield a cumulative reflection of a 
long–term drug abuse.
Hair analysis is a reliable tool for confirming or 
excluding chronic drug abuse (3–6). As hair grows 
approximately 1 cm a month, the history of drug 
abuse can be traced months back, depending on 
the length of the hair.
As a biological matrix, hair has particular 
advantages: it can easily be obtained, it is not readily 
adulterated and, thanks to its stability, it can be 
stored and transported without particular precaution. 
Cocaine is the leading subjects in literature on hair 
analysis, and is followed by opiates and amphetamines 
(7). This paper describes gas chromatographic/mass 
spectrometric (GC/MS) methods developed for the 
determination of opiates (morphine, codeine, heroin 
and 6–acetylmorphine), cocaine, methadone and 
amphetamines (amphetamine; methamphetamine; 
3,4–methylenedioxyamphetamine, MDA; and 3,4– 
methylenedioxymethamphetamine, MDMA, “Ecstasy “) 
in hair (8). The methods had been applied for over 
two years in the analysis of hair of young subjects 
suspected for drug abuse. In addition, the paper gives 
an evaluation of the incidence of drug abuse in young 
people in Croatia.
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This article gives a brief account of a two–year experience with gas chromatography/mass spectrometry 
methods developed for the analysis of opiates (morphine, codeine, heroin and 6–acetylmorphine), cocaine, 
methadone, and amphetamines (amphetamine; methamphetamine; 3,4–methylenedioxyamphetamine 
– MDA, and 3,4–methylenedioxymethamphetamine – MDMA, Ecstasy) in hair . The methods developed 
were reproducible (RSD=5.0–16.1%), accurate (85.1–100.6%) and sensitive (LD=0.05–0.30 ng/mg). They 
were applied in the analysis of 221 hair samples obtained from young subjects aged 15–25 years, who were 
suspected of drug abuse. Seventy–seven hair samples were found positive for drugs of abuse. Forty–two 
subjects were found to have consumed amphetamine, of whom 40 were found MDMA (Ecstasy). Heroin 
consumption, based on positive 6–acetylmorphine, was found in 26 subjects. Cocaine alone was present 
in three subjects, two were found cocaine and heroin, two cocaine and methadone, and one cocaine and 
MDMA. These results could indicate the trend in drug abuse among young people in Croatia.





All solvents and chemicals were of the analytical 
grade. Morphine sulphate, codeine, heroin 
hydrochloride, methadone hydrochloride, and 
cocaine hydrochloride were obtained from Sigma 
Chemical (St. Louis, MO, USA), 6–acetylmorphine, 
amphetamine, methamphetamine, MDA and MDMA 
from Radian International LLC (Austin, TX, USA), 
propionic acid anhydride and heptafluorobutyric 
anhydride (HFBA) from Fluka AG (Buchs SG, 
Switzerland), pyridine from Kemika (Zagreb, Croatia), 
and Bond Elut Certify columns (10 ml, 130 mg) from 
Varian (Harbor City, CA, USA).
Hair samples
Hair samples were collected from 221 young 
people aged between 15 and 25 years. As the Institute 
for Medical Research and Occupational Health is the 
only institution in Croatia with a laboratory equipped 
for the analysis of drugs of abuse in hair, the subjects 
were either sent by the regional drug abuse prevention 
centres or came on their own, most often with their 
parents. A tress of hair of about 5 mm in diameter was 
cut as close to the rear top of the scalp as possible, 
folded in aluminium foil, and the proximal and the 
distal ends were marked. The samples were stored 
under dry conditions at room temperature until 
analysis. We analysed samples 2–4 cm long, which 
corresponds to the timeline of approximately 2–4 
months.
Hair analysis
GC/MS methods for detecting drug in hair 
mostly differ between each other in the washing 
and extraction procedure. We decided to wash hair 
samples in dichloromethane twice, because our own 
tests showed that the third wash was always negative, 
although the two previous washes were positive. After 
washing, the hair was dried and cut into very small 
pieces of less than 1 mm. We analysed 50 mg of 
each sample.
Methanol was chosen for extracting opiates and 
cocaine. The best recoveries for amphetamines were 
obtained after alkaline hydrolysis of hair.
A variety of derivatisation reagents are used in the 
analysis of drugs of abuse. We found that a mixture 
of propionic acid anhydride and pyridine was very 
convenient and superior to N,O–bis(trimethylsilyl) 
trifluoroacetamide for the derivatisation of codeine, 
6–acetylmorphine, and morphine. Heptafluorobutyric 
anhydride is recommended for the derivatisation of 
amphetamines.
It was not possible to analyse all drugs using the 
same procedure. They were divided in groups A and 
B, and each was analysed separately.
GROUP A: MORPHINE, CODEINE, HEROIN, 6–ACETYLMOR-
PHINE, METHADONE AND COCAINE
Methanol was added to 50 mg of hair in a screw–
cap tube. The samples were incubated for 18 h in a 
40 °C water bath. The methanol was then collected, 
the remaining hair was rinsed with methanol, and both 
fractions were evaporated to dryness at 40 °C under 
a stream of nitrogen.
Clean–up procedure and derivatisation
Solid–phase extraction was used to purify hair 
extracts prior to analysis. Bond Elut Certify columns 
were conditioned with methanol and 0.1 M phosphate 
buffer at pH=6.0. After methanol evaporation, the 
dry hair residue was added 0.1 M phosphate buffer at 
pH=6.0 and was poured into conditioned columns. 
Deionised water, 0.1 M acetic acid, and methanol 
were then added in that order. The cartridges were 
dried under full vacuum and eluted with mixture of 
dichloromethane:2–propanol:amonium hydroxide (80:
20:2, v/v/v). The eluents were collected in glass tubes 
and evaporated to dryness at 40 °C under a stream 
of nitrogen. One hundred microlitres of pyridine and 
30 µl of propionic acid anhydride were added to the 
residues and heated at 60 °C for 30 min. Followed 
evaporation to dryness, reconstitution in ethyl acetate, 
and GC/MS analysis.
GROUP B: AMPHETAMINES
Every 50 mg hair sample received 1 M sodium 
hydroxide. The samples were hydrolysed for 20 
min at 70 °C and then cooled. Followed extraction 
with ethyl acetate and evaporation to dryness in the 
presence of a mixture of methanol:hydrochloric acid 
(99:1, v/v). Fifty microlitres of ethyl acetate and 50 µl 
of HFBA were added to the dry residue and heated 
at 60 °C for 30 min. Followed evaporation to dryness, 
reconstitution in ethyl acetate, and GC/MS analysis.
Each group of samples (A, B) included standards 
for drug abuse/metabolites, negative control, and the 
genuine positive sample.
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Standard preparation
Stock solutions containing 2 µg/ml of A) 
morphine sulphate, codeine, heroin hydrochloride, 
6–acetylmorphine, methadone hydrochloride, 
and cocaine hydrochloride, and B) amphetamine, 
methamphetamine, MDA, and MDMA were prepared 
in methanol and stored at –20 °C. Standard calibration 
curves were obtained through the described method 
using 20, 50, 100, 200, 400 and 800 ng of the stock 
solution A or B, and 50 mg of blank control hair, 
previously washed and cut into very small pieces. 
Blank control hair samples were obtained from 
co–workers in our laboratory.
GC–MS analysis
The analysis was performed using a Varian 3400 
CX GC with Saturn ion trap mass spectrometer (mass 
selective detector, MSD). The chromatographic column 
was RTx–5 (5% diphenyl–95% dimethyl polysiloxane, 
30 m, 0.25 mm i.d, with a film thick 0.25 µm). For the 
analysis of the group A of drugs (morphine, codeine, 
heroin, 6–acetylmorphine, methadone and cocaine), 
the initial column temperature of 50 °C was held for 
1 min, then programmed to 300 °C at 50 °C/min, 
and held for 6 min. For the analysis of the group B 
of drugs (amphetamine, methamphetamine, MDA, 
and MDMA), the initial column temperature of 50 °C 
was held for 1 min, then programmed to 225 °C at 
20 °C/min, and then to 260 °C at 50 °C/min and 
held for 1 min. Ultra–pure grade helium was used 
as the carrier gas at a flow rate of about 1 ml/min. 
Septum–equipped Programmable Injector (SPI) was 
used; the initial temperature was 40 °C, held for 0.1 
min, programmed to 280 °C at 200 °C/min and held 
for 8 min. The transfer line temperature was 260 °C.
The external standard method of quantitation 
was used for the analytes in both groups. For each 
analyte the following ions were used: methadone, 
m/z 72, 309, 165; cocaine, m/z 182, 82, 303; 
codeine–propionyl, m/z 355, 282, 341; heroin, 
m/z 310, 327, 369; 6–acetylmorphine–propionyl, 
m/z 327, 268, 383; morphine–dipropionyl, m/z 341, 
268, 397; and amphetamine–HFBA, m/z 118, 240, 
91; methamphetamine–HFBA, m/z 254, 210, 118; 
MDA–HFBA, m/z 135, 162, 240, and MDMA–HFBA, 
m/z 162, 254, 210. The underlined ions were used 
for quantitation.
RESULTS AND DISCUSSION
Figure 1 shows the total and selected ion 
chromatograms of amphetamine–HFBA, 
methamphetamine–HFBA, MDA–HFBA and 
MDMA–HFBA in control hair fortified with 4 ng/mg 
of each analyte (a) and in the hair of amphetamine 
abusers (amphetamine 2.78; MDA 0.91; MDMA 11.24 
ng/mg) (b).
Figure 2 shows the total and selected ion 
chromatograms of cocaine, codeine–propionyl, 
heroin, 6–acetylmorphine–propionyl and morphine–
dipropionyl in control hair fortified with 4 ng/mg of 
each analyte(a), and in drug abusers’ hair (cocaine 
5.99; codeine 2.51; heroin 5.58; 6–acetylmorphine 
9.57; morphine 6.52 ng/mg) (b). 
The main parameters for the quantitative validation 
of the developed methods are shown in Table 1. The 
precision (N=8), expressed as relative standard 
deviation (RSD), was <10% for all analytes except 
cocaine and heroin. The accuracy was >86% for 
all analytes except MDA. The limit of detection (LD) 
ranged from 0.05 to 0.30 ng/mg. The correlation 
coefficients of the calibration curves were >0.997 for 
all analytes. External quality assessment was verified 
through participation in the programme Proficiency 
Test on Drugs of Abuse in Hair, organized by the 
Society of Hair Testing, Munich, Germany.










Methadone 6.9 87.5 0.30
Cocaine 16.1 96.3 0.20
Codeine 8.2 100.6 0.10
Heroin 12.6 91.3 0.20
6–acetylmorphine 6.5 98.8 0.05
Morphine 6.3 99.4 0.10
Amphetamine 7.8 88.0 0.20
Methamphetamine 5.2 97.2 0.05
MDA 8.3 85.1 0.20
MDMA 5.0 90.6 0.10
The described methods were applied in the 
analysis of 221 hair samples taken from young 
subjects (15–25 years of age) suspected of drug 
abuse. Seventy seven samples (women N=17, men 
N=60) were found positive for drug of abuse, and 
144 were negative.
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Figure 1 
a) Total and selected ion chromatograms of amphetamine–HFBA (m/z 118), methamphetamine–HFBA (m/z 254), MDA–HFBA (m/z 135), and 
MDMA–HFBA (m/z 162) in control hair fortified with 4 ng/ml of each analyte.
b) Total and selected ion chromatograms of amphetamine abusers’ hair: amphetamine 2.78 ; MDA 0.91; MDMA 11.24 ng/mg.
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Figure 2 
a) Total and selected ion chromatograms of cocaine (m/z 182), codeine–propionyl (m/z 355), heroin (m/z 310), 6–acetylmorphine–propionyl (m/z 
327), and morphine–dipropionyl (m/z 341) in control hair fortified with 4 ng/mg of each analyte.
b) Total and selected ion chromatograms of heroin and cocaine abusers’ hair: cocaine 5.99; codeine 2.51; heroin 5.58; 6–acetylmorphine 9.57; 
morphine 6.52 ng/mg.
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Table 2 summarises positive results of drugs of 
abuse (N=77) in which one or more than one kind 
of drug were found. In most subjects, amphetamines 
(N=42) were found alone (N=39) or with other 
drugs (N=3). The leading amphetamine was MDMA, 
which confirmed dominant “Ecstasy” consumption. 
“Ecstasy” is believed to be popular as a “dance drug” 
among the young, particularly those who attend “rave” 
parties.
Table 2  Percentage of hair positive samples (N=77) for amphetamines, 





Amphetamines only 39 50.6
Opiates only 15 19.5
Cocaine only 3 3.9
Methadone only 6 7.8
Amphetamines / cocaine 1 1.3
Opiates / cocaine 1 1.3
Opiates / amphetamines 2 2.6
Opiates / methadone 7 9.1
Opiates / cocaine / methadone 1 1.3
Cocaine / methadone 2 2.6
Figure 3 shows positive amphetamine findings. 
The leading MDMA ranged from 0.56 to 64.42 ng/mg. 
In most hair samples (78.6%), MDMA was found in 
mass fractions of up to 5.0 ng/mg, which reflects the 
occasional and the most common, “party” abuse of 
1–2 tablets in average. Only three hair samples stand 
out with high MDMA mass fractions, that is, 64.42; 
23.87, and 18.62 ng/mg. It was not even possible 
to represent the real MDMA mass fraction of 64.42 
ng/mg in Figure 3.
Opiates alone were detected in 15 hair samples, 
with cocaine in one sample, amphetamines in two, 
methadone in seven, and methadone plus cocaine 
in one sample. The marker of heroin consumption, 
6–acetylmorphine, was found in all these samples. 
Both 6–acetylmorphine and morphine were found in 
23 subjects. The 6–acetylmorphine/morphine ratio 
(mean: 1.98; median: 2.28; range: 0.69–6.54) was 
similar to that found by Moeller and co–workers (9). 
Higher concentrations of 6–acetylmorphine than 
those of morphine are usual for heroin consumers. 
Only rarely does the morphine concentration exceed 
the concentration of 6–acetylmorphine (7, 9, 10). We 
recorded only three such cases among our subjects. 
The morphine/6–acetylmorphine ratio (mean: 0.61; 
median: 0.58; range: 0.15–1.45) is in accordance 
with the results of Gaillard and Pepin (4). Heroin was 
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Figure 3 Mass fractions of amphetamines (amphetamine, methamphetamine, MDA, and MDMA) in hair. *The real MDMA mass fraction is 64.42 ng/mg. 
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found in only 12 hair samples, which is consistent with 
literature (11, 12). The finding of codeine in only seven 
hair samples is a surprisingly low rate, having in mind 
the notorious impurity of heroin sold in the streets.
Figure 4 shows 26 positive cases for opiates in 
hair. The confirmation marker for heroin consumption, 
6– acetylmorphine (6–MAM), ranged from 0.57 to 6.82 
ng/mg. Cocaine was present in eight hair samples; in 
three of them together with heroin, and in one with 
MDMA. Methadone was found in 16 hair samples.
It is rather unexpected that we found only 77 
positive results in the total of 221 analysed hair 
samples. However, there is a plausible explanation 
for that. Most hair samples were taken from young 
adolescents (15–17 years of age) whose parents were 
upset by their change in behaviour and poor results in 
school, which led them to suspect that their children 
were taking drugs. This suspicion was not altogether 
unjustified as most of them smoked marihuana (1). 
However, we have not yet developed a method for 
the analysis of marihuana’s psychoactive constituent 
tetrahydrocannabinol in hair. One reason is that, in 
contrast to other drugs whose excretion through 
urine is relatively quick, the marihuana metabolite 
11–nor–9–tetrhidrocannabinol–9–carboxylic acid can 
be detected for up to two months after the chronic 
use of marihuana or hashish (2).
All but five women and three men had coloured 
and bleached hair. Only three women with treated 
hair were found 6–acetylmorphine without morphine. 
There are several reports about a lower hair drug 
content which is associated with the cosmetic 
treatment of hair (13–16).
CONCLUSION
The described GC/MS methods used in our 
laboratory for over two years have been validated and 
found acceptable for the routine analysis of drugs 
of abuse in hair. Despite uncertainties related to the 
analysis of coloured and bleached hair, the methods 
were able to confirm drug abuse with high reliability. 
This study also indicates the trend in drug abuse 
among young people in Croatia.
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Figure 4 Mass fractions of 6–acetylmorphine (6–MAM), heroin, morphine, and codeine in hair.
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Sažetak
PROCJENA ZLOPORABE DROGA ANALIZOM KOSE: DVOGODIŠNJE ISKUSTVO
Razvijene su GC/MS metode za analizu opijata (morfin, kodein, heroin i 6–acetilmorfin), kokaina, metadona 
i amfetamina (amfetamin; metamfetamin; 3,4–metilendioksiamfetamin –MDA i 3,4–metilendioksimetam-
fetamin – MDMA) u kosi. Osjetljivost, preciznost i točnost metode određene su za sve analite. Opisane 
metode primijenjene su pri identifikaciji zloporabe droga u kosi 221 mlade osobe (15–25 god.) za koje 
se sumnjalo da uzimaju drogu. U 77 osoba dokazano je uzimanje droga, dok su u uzorcima kose 144–ju 
ispitanika rezultati negativni. U 54,5% (N=42) osoba za koje je utvrđeno da uzimaju droge nađeni su 
amfetamini, pretežno MDMA (N=40), što upućuje na uzimanje tableta “Ecstasy”. Konzumiranje heroina 
dokazano je u 33,8% (N=26) osoba na temelju prisutnosti 6–acetilmorfina, jedinog specifičnog metabolita 
heroina. Uzimanje kokaina dokazano je u osam ispitanika.
Razrađenim metodama moguće je procijeniti učestalost i vrstu droga koju uzima mlada populacija u 
Hrvatskoj.
KLJUČNE RIJEČI: amfetamini, kokain, kvantitativno određivanje, metadon, opijati, plinska 
kromatografija/spektrometrija masa
